Management of Patients with Recurrent and Metachronous Oligometastatic Prostate Cancer in the Era of PSMA PET

Management of Patients with Recurrent and Metachronous Oligometastatic Prostate Cancer in the Era of PSMA PET

Prostate-specific membrane antigen (PSMA) positron emission tomography (PET) scans have higher sensitivity and specificity for detecting lymph nodes or metastatic disease relative to conventional imaging in prostate cancer staging. Since its FDA approval and incorporation into treatment guidelines,...

Full description

Bibliographic Details
Main Authors: Ali Sabbagh, Osama Mohamad, Katie E. Lichter, Thomas A. Hope
Format: Article
Language:English
Published: MDPI AG 2022-12-01
Series:Cancers
Subjects:
prostate cancer
PET PSMA
radiotherapy
oligometastasis
biochemical recurrence
Online Access:https://www.mdpi.com/2072-6694/14/24/6194

Internet

https://www.mdpi.com/2072-6694/14/24/6194

Similar Items